Overview: AFB Sputum TestIntroduction: The AFB Sputum Test detects acid-fast bacilli (AFB) to diagnose tuberculosis, causing cough or weight loss. Aligned with 2023 CDC guidelines, it uses microscopy for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in clinical pathology for patients with suspected tuberculosis.
Other Names: Acid-Fast Bacilli Sputum Assay, TB Smear Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: AFB testing began in the 1880s with Ziehl-Neelsen staining. Microscopy methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects AFB to diagnose tuberculosis, guides treatment, and evaluates patients with cough or weight loss.
Test Parameters: 1. AFB Presence
Pretest Condition: No fasting required. Collect sputum. Report history of cough, weight loss, or tuberculosis exposure.
Specimen: Sputum (sterile container, 5-10 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document cough, weight loss, or history of tuberculosis exposure. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, tuberculosis implications, and risks of sample collection.
Procedural Considerations: Uses Ziehl-Neelsen or auramine staining and microscopy to detect AFB. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for tuberculosis diagnosis.
Factors Affecting Result Accuracy: Improper sputum collection or low bacterial load can affect results. Antibiotic use may reduce sensitivity.
Clinical Significance: Positive AFB confirms tuberculosis, guiding anti-tubercular therapy. Negative results may require culture or PCR testing.
Specialist Consultation: Consult an infectious disease specialist or pulmonologist for result interpretation and treatment planning.
Additional Supporting Tests: TB culture, GeneXpert PCR, or chest X-ray to confirm tuberculosis diagnosis.
Test Limitations: Low sensitivity for early tuberculosis; clinical correlation is needed. Sample quality affects accuracy.
References: CDC Tuberculosis Guidelines, 2023; Clinical Infectious Diseases, Nahid P, 2022.
